Genelux Corp (NASDAQ:GNLX) has a beta value of -1.72 and has seen 0.55 million shares traded in the recent trading session. The company, currently valued at $109.32M, closed the recent trade at $3.16 per share which meant it lost -$0.03 on the day or -0.78% during that session. The GNLX stock price is -601.27% off its 52-week high price of $22.16 and 49.37% above the 52-week low of $1.60. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.11 million shares traded. The 3-month trading volume is 137.90K shares.
The consensus among analysts is that Genelux Corp (GNLX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.18.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Genelux Corp (NASDAQ:GNLX) trade information
Sporting -0.78% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the GNLX stock price touched $3.16 or saw a rise of 12.22%. Year-to-date, Genelux Corp shares have moved -77.41%, while the 5-day performance has seen it change 20.80%. Over the past 30 days, the shares of Genelux Corp (NASDAQ:GNLX) have changed 24.61%. Short interest in the company has seen 1.12 million shares shorted with days to cover at 5.72.
Genelux Corp (GNLX) estimates and forecasts
Figures show that Genelux Corp shares have outperformed across the wider relevant industry. The company’s shares have lost -12.45% over the past 6 months, with this year growth rate of 21.05%, compared to 17.40% for the industry. Revenue growth from the last financial year stood is estimated to be -94.10%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -23.84% over the past 5 years.
GNLX Dividends
Genelux Corp is expected to release its next earnings report on 2024-Aug-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Genelux Corp (NASDAQ:GNLX)’s Major holders
Insiders own 17.85% of the company shares, while shares held by institutions stand at 20.69% with a share float percentage of 25.18%. Investors are also buoyed by the number of investors in a company, with Genelux Corp having a total of 88.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Jun 30, 2024, the former fund manager holds about 1.82% shares in the company for having 629.17 shares of worth $1.99 million while later fund manager owns 284.12 shares of worth $0.9 million as of Jun 30, 2024, which makes it owner of about 0.82% of company’s outstanding stock.
